BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21303380)

  • 1. Molecular pathogenesis of hepatocellular carcinoma.
    Cornellà H; Alsinet C; Villanueva A
    Alcohol Clin Exp Res; 2011 May; 35(5):821-5. PubMed ID: 21303380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and signaling pathways in hepatocellular carcinoma.
    Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
    Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M
    Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K; Masugi Y; Sakamoto M
    Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways and gene expression profiles in hepatocellular carcinoma.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH; Moran DM; Jin X; Koniaris LG
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative drive and liver carcinogenesis: too much of a good thing?
    Teoh NC
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the natural history of hepatocellular carcinoma.
    Trevisani F; Cantarini MC; Wands JR; Bernardi M
    Carcinogenesis; 2008 Jul; 29(7):1299-305. PubMed ID: 18515282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R; Just PA; Perret C
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signatures and prognosis of hepatocellular carcinoma.
    Hoshida Y
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
    Marquardt JU; Galle PR; Teufel A
    J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis viruses and hepatocarcinogenesis].
    Kiss A; Lotz G; Kaposi NP; Schaff Z
    Orv Hetil; 2002 Jan; 143(2):83-6. PubMed ID: 11868453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE
    Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
    Whittaker S; Marais R; Zhu AX
    Oncogene; 2010 Sep; 29(36):4989-5005. PubMed ID: 20639898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.